PYPD vs QNRX

PolyPid Ltd. vs Quoin Pharmaceuticals, Ltd. — Valuation Comparison 2026

PYPD

Biotechnology
PolyPid Ltd.
Quality
1.8
out of 10
Value Trap
Price
$4.76
Last close
Models
9/13
Active
VS

QNRX

Biotechnology
Quoin Pharmaceuticals, Ltd.
Quality
2.0
out of 10
Value Trap
Price
$4.94
Last close
Models
6/13
Active

Model-by-Model Comparison

ModelType PYPD Fair ValuePYPD Upside QNRX Fair ValueQNRX Upside
Bayesian DCF Intrinsic $1.26 -73.5% $1.31 -73.5%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $•••.•• ••.•% $•••.•• ••.•%
Dynamic NAV Asset-Based $0.30 -93.7% $4.38 -12.4%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $26.22 +450.9%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for PYPD vs QNRX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

PYPD vs QNRX — Which Stock Is More Undervalued?

QNRX scores higher with a 2.0/10 quality rating vs PYPD's 1.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing PolyPid Ltd. (PYPD) and Quoin Pharmaceuticals, Ltd. (QNRX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

PYPD currently trades at $4.76 with a QOC of 1.8/10, while QNRX trades at $4.94 with a QOC of 2.0/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).